Full thickness
Two layers, amnion and chorion, at full thickness.
Placental tissue grafts
Reeva FT™ is a sterile, full-thickness, dual layered amnion/chorion allograft, designed to cover and protect the wound during treatment.
Reeva FT is derived from a prescreened mother with a planned delivery, and manufactured in compliance with FDA regulations and AATB guidance.

Key Features
Two layers, amnion and chorion, at full thickness.
Dehydrated extracellular matrix that acts as a scaffold supporting the native tissue.
Sticks to wounds, including those with irregular surfaces.
Processed to keep the tissue's native structure, then dehydrated and terminally sterilized.
Sizes & Ordering
Reeva FT comes in 6 sizes, each with its own order code.
| Order code | Size |
|---|---|
| RVA-020202 | 2 × 2 cm (4 cm²) |
| RVA-020203 | 2 × 3 cm (6 cm²) |
| RVA-020404 | 4 × 4 cm (16 cm²) |
| RVA-020406 | 4 × 6 cm (24 cm²) |
| RVA-020408 | 4 × 8 cm (32 cm²) |
| RVA-021015 | 10 × 15 cm (150 cm²) |
Need a size that is not listed? Ask us.
Information for Clinical Teams
Practical information and source documents for your team's evaluation.
From the maker's information. Always follow the maker's instructions for use, its warnings, and your facility's protocols.
No billing code is listed for Reeva FT yet.
Reimbursement is not guaranteed. Ask us for the maker's reimbursement resources.
DocumentsProduct sheet. Sent by email on request.Ask for a document
All trademarks belong to their owners.
The DRI Experience
Your partnership with DRI doesn't end with product selection.
We take the time to understand each provider's clinical and operational priorities, from hospitals and wound care centers to independent physician practices, mobile clinics, home health organizations, skilled nursing facilities and long-term care providers.
Expect thoughtful guidance, responsive communication, and personalized attention every step of the way.
24/7
Live Assistance
Real people. Real answers. When you need us.
FAQ
The maker's product sheet does not list one yet. Ask us and we will get the latest from the maker.
The maker states that the FDA Tissue Reference Group has confirmed Reeva FT meets the criteria for regulation solely under Section 361 of the PHS Act, as defined in 21 CFR Part 1271.
Yes. We can send the maker's product information and instructions for use by email. Use “Ask for a document” on this page, or just ask.
Let’s Build Something Exceptional
Whether you serve patients in a hospital, independent practice, mobile clinic or home-based setting, DRI Wound Care is ready to explore the right solution with you.
Innovative by Vision. Personal by Nature. Exceptional by Commitment.
More Products

Autologous wound care
A whole blood clot made at point of care from the patient's own blood. No centrifuge, ready in about 5 minutes.
View details
Placental tissue grafts
A three-layer placental tissue graft, with a thick chorion core between two amnion layers.
View details
Placental tissue grafts
A sterile membrane allograft that acts as a scaffold in partial- and full-thickness acute and chronic wounds.
View details